ArticleCell death and differentiation2020

The deubiquitylase USP2 maintains ErbB2 abundance via counteracting endocytic degradation and represents a therapeutic target in ErbB2-positive breast cancer.

Jinrui Zhang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.